Aug 15
Opportunity
Participants expect some flexibility and do not want clinical trial participation to significantly impact their normal daily schedule. Sponsors should consider exploring solutions that allow participants to more easily find and select times for appointments, especially with increased flexibility and more diverse procedure locations.
Considerations to Help Action the Opportunity
- Understand the individual needs of each participant and their preferences
- Partner with sites to build flexibility into the clinical trial design by providing timing and location options for visits
- Explore decentralized clinical trial options, such as telemedicine and the use of local clinics and sites
Value and Potential Benefits
- Increases flexibility and ease of scheduling
- Encourages patient engagement and empowers patients
- Reduces the barriers to finding and attending appointments potentially leading to better compliance and retention
Related Blog Posts
Making AI work where it matters, with Rob DiCicco
In a new pharmaphorum podcast, web editor Nicole Raleigh was joined by Rob DiCicco, vice president of portfolio management at Transcelerate Biopharma Inc, for a conversation on the barriers and the breakthroughs in making AI work in drug development and clinical trials. Read the full article featuring Rob DiCicco from Pharmaphorum here.
From Vision to Value: A Blueprint for Implementing Industry Consortia Innovations
Our healthcare landscape is rapidly evolving and presenting us with complex challenges: modernizing clinical trials, ethically integrating artificial intelligence, and delivering patient-centric care. No single organization can tackle these issues alone. Read the full article from DIA Global Forum here.
TransCelerate Highlights Digital Momentum and Global Collaboration in 2025 Annual Report
TransCelerate BioPharma has released its 2025 annual report, titled The Power of Forward, outlining a year defined by continued digital adoption, regulatory collaboration, and expansion of pragmatic approaches to clinical development. Read the full article featuring Janice Chang from Applied Clinical Trials here.
